1999
DOI: 10.1046/j.1463-1326.1999.00025.x
|View full text |Cite
|
Sign up to set email alerts
|

Sudden death in type 1 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 84 publications
(93 reference statements)
0
28
0
Order By: Relevance
“…In the background population these deaths are usually classified as CAD. For diabetic patients there is reason to believe that both cardiac autonomic dysfunction and concomitant hypoglycaemia are involved, and that malignant cardiac dysrhythmias might be a common final pathway [38]. It has been recognised that patients with cardiac autonomic neuropathy secondary to diabetes sometimes die a sudden and unexpected death without an obvious cause apparent at autopsy [39].…”
Section: Discussionmentioning
confidence: 99%
“…In the background population these deaths are usually classified as CAD. For diabetic patients there is reason to believe that both cardiac autonomic dysfunction and concomitant hypoglycaemia are involved, and that malignant cardiac dysrhythmias might be a common final pathway [38]. It has been recognised that patients with cardiac autonomic neuropathy secondary to diabetes sometimes die a sudden and unexpected death without an obvious cause apparent at autopsy [39].…”
Section: Discussionmentioning
confidence: 99%
“…These data support a potential role for nonanatomic factors, such as autonomic neuropathy, long QT syndrome, or hypoglycemia, in the precipitation of sudden death in type I diabetic patients. 24 Clinical studies have shown that diabetes is associated with positive 25 or negative/absence of remodeling. 26 The current study supports the notion that diabetic subjects are more likely to show positive remodeling.…”
Section: Figurementioning
confidence: 99%
“…Hyperglycaemia activates multiple phenomena. 21 Many of these favour the development of atherosclerosis; others play a role in the development of microvascular complications, which can also be risk factors for cardiovascular disease, 22 such as cardiac autonomic neuropathy 23 and albuminuria. 24 Cardiac failure is another documented risk factor for premature death in this patient group.…”
Section: 13mentioning
confidence: 99%